Cargando…
Heparan sulfate: Resilience factor and therapeutic target for cocaine abuse
Substance abuse is a pressing problem with few therapeutic options. The identification of addiction resilience factors is a potential strategy to identify new mechanisms that can be targeted therapeutically. Heparan sulfate (HS) is a linear sulfated polysaccharide that is a component of the cell sur...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5654972/ https://www.ncbi.nlm.nih.gov/pubmed/29066725 http://dx.doi.org/10.1038/s41598-017-13960-6 |
_version_ | 1783273452400017408 |
---|---|
author | Chen, Jihuan Kawamura, Tomoya Sethi, Manveen K. Zaia, Joseph Repunte-Canonigo, Vez Sanna, Pietro Paolo |
author_facet | Chen, Jihuan Kawamura, Tomoya Sethi, Manveen K. Zaia, Joseph Repunte-Canonigo, Vez Sanna, Pietro Paolo |
author_sort | Chen, Jihuan |
collection | PubMed |
description | Substance abuse is a pressing problem with few therapeutic options. The identification of addiction resilience factors is a potential strategy to identify new mechanisms that can be targeted therapeutically. Heparan sulfate (HS) is a linear sulfated polysaccharide that is a component of the cell surface and extracellular matrix. Heparan sulfate modulates the activity and distribution of a set of negatively charged signaling peptides and proteins — known as the HS interactome — by acting as a co-receptor or alternative receptor for growth factors and other signaling peptides and sequestering and localizing them, among other actions. Here, we show that stimulants like cocaine and methamphetamine greatly increase HS content and sulfation levels in the lateral hypothalamus and that HS contributes to the regulation of cocaine seeking and taking. The ability of the HS-binding neuropeptide glial-cell-line-derived neurotrophic factor (GDNF) to increase cocaine intake was potentiated by a deletion that abolished its HS binding. The delivery of heparanase, the endo-β-D-glucuronidase that degrades HS, accelerated the acquisition of cocaine self-administration and promoted persistent responding during extinction. Altogether, these results indicate that HS is a resilience factor for cocaine abuse and a novel therapeutic target for the treatment of cocaine addiction. |
format | Online Article Text |
id | pubmed-5654972 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-56549722017-10-31 Heparan sulfate: Resilience factor and therapeutic target for cocaine abuse Chen, Jihuan Kawamura, Tomoya Sethi, Manveen K. Zaia, Joseph Repunte-Canonigo, Vez Sanna, Pietro Paolo Sci Rep Article Substance abuse is a pressing problem with few therapeutic options. The identification of addiction resilience factors is a potential strategy to identify new mechanisms that can be targeted therapeutically. Heparan sulfate (HS) is a linear sulfated polysaccharide that is a component of the cell surface and extracellular matrix. Heparan sulfate modulates the activity and distribution of a set of negatively charged signaling peptides and proteins — known as the HS interactome — by acting as a co-receptor or alternative receptor for growth factors and other signaling peptides and sequestering and localizing them, among other actions. Here, we show that stimulants like cocaine and methamphetamine greatly increase HS content and sulfation levels in the lateral hypothalamus and that HS contributes to the regulation of cocaine seeking and taking. The ability of the HS-binding neuropeptide glial-cell-line-derived neurotrophic factor (GDNF) to increase cocaine intake was potentiated by a deletion that abolished its HS binding. The delivery of heparanase, the endo-β-D-glucuronidase that degrades HS, accelerated the acquisition of cocaine self-administration and promoted persistent responding during extinction. Altogether, these results indicate that HS is a resilience factor for cocaine abuse and a novel therapeutic target for the treatment of cocaine addiction. Nature Publishing Group UK 2017-10-24 /pmc/articles/PMC5654972/ /pubmed/29066725 http://dx.doi.org/10.1038/s41598-017-13960-6 Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Chen, Jihuan Kawamura, Tomoya Sethi, Manveen K. Zaia, Joseph Repunte-Canonigo, Vez Sanna, Pietro Paolo Heparan sulfate: Resilience factor and therapeutic target for cocaine abuse |
title | Heparan sulfate: Resilience factor and therapeutic target for cocaine abuse |
title_full | Heparan sulfate: Resilience factor and therapeutic target for cocaine abuse |
title_fullStr | Heparan sulfate: Resilience factor and therapeutic target for cocaine abuse |
title_full_unstemmed | Heparan sulfate: Resilience factor and therapeutic target for cocaine abuse |
title_short | Heparan sulfate: Resilience factor and therapeutic target for cocaine abuse |
title_sort | heparan sulfate: resilience factor and therapeutic target for cocaine abuse |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5654972/ https://www.ncbi.nlm.nih.gov/pubmed/29066725 http://dx.doi.org/10.1038/s41598-017-13960-6 |
work_keys_str_mv | AT chenjihuan heparansulfateresiliencefactorandtherapeutictargetforcocaineabuse AT kawamuratomoya heparansulfateresiliencefactorandtherapeutictargetforcocaineabuse AT sethimanveenk heparansulfateresiliencefactorandtherapeutictargetforcocaineabuse AT zaiajoseph heparansulfateresiliencefactorandtherapeutictargetforcocaineabuse AT repuntecanonigovez heparansulfateresiliencefactorandtherapeutictargetforcocaineabuse AT sannapietropaolo heparansulfateresiliencefactorandtherapeutictargetforcocaineabuse |